ABSTRACT Patients with Duchenne muscular dystrophy develop progressive ventilatory muscle weakness and often die of respiratory complications. Recurrent, often profound, hypoxaemia has been shown in a previous study by this group to occur during rapid eye movement (REM) sleep in these patients before they develop sleep symptoms. In this study the efficacy and physiological effects of nocturnal oxygen in such patients have been assessed. Seven patients with Duchenne muscular dystrophy (age range 16-22 years; mean vital capacity 1-37 litres) with normal arterial blood gas tensions when awake were investigated by standard overnight polysomnography on an acclimatisation night followed by two successive nights on which they received room air and nasal oxygen (2 litres/min) respectively in random order. Total sleep time, proportion of REM and non-REM sleep, and frequency and duration of arousals were similar on the two nights. When breathing air six of the seven subjects developed oxygen desaturation of more than 5% during REM sleep. With oxygen only one subject showed any oxygen desaturation exceeding 2-5%. Oxygen desaturation was associated with periods of hypopnoea or cessation of respiratory effort. The mean duration of episodes of hypopnoea and apnoea was prolonged during oxygen breathing by 19% and the mean duration of episodes during REM sleep by 33% (the proportion of REM sleep associated with hypopnoea and apnoea increased in all subjects). Heart rate in non-REM sleep fell by 9 3%; heart rate variation in REM and non-REM sleep was unchanged. These acute studies show that oxygen reduces the sleep hypoxaemia associated with respiratory muscle weakness; whether long term treatment will be possible or desirable is not clear as oxygen potentiates the underlying ventilatory disturbance.
Introduction
Patients with Duchenne muscular dystrophy die prematurely, usually before the age of 25 years and usually from respiratory muscle failure. ' We have shown2 that profound hypoxaemia is common during rapid eye movement (REM) sleep in patients with advanced Duchenne muscular dystrophy, despite normal arterial blood gas tensions when they are awake and in the absence of sleep symptoms. The prognostic importance of this degree of sleep hypoxaemia is not established, but prevention may be beneficial. Aggressive management of respiratory failure with assisted ventilation in patients with progressive neuromuscular disease may prevent hypoxaemia but it poses ethical problems.3 Oxygen treatment is a logical choice to prevent sleep hypoxAddress for reprint requests: Dr P M A Calverley, Mersey Regional Thoracic Unit, Fazakerley Hospital, Liverpool L19 7AL.
Accepted 22 September 1989 aemia, being non-invasive and readily acceptable. We have used overnight polysomnography to study whether low flow nocturnal oxygen given to abolish sleep hypoxaemia in patients with advanced Duchenne muscular dystrophy is beneficial.
PATIENTS
We studied seven patients with Duchenne muscular dystrophy aged 16- Episodes with apnoea contained periods exceeding 10 seconds of zero "sum" and airflow signal ("central" apnoea) or diminished "sum" but absent airflow ("obstructive" apnoea). Desaturation was defined as a fall in oxygen saturation of more than 5% from the preceding stable (usually non-REM) value. The mean heart rate during REM and non-REM sleep was derived from three one minute periods of REM and of stage 3 non-REM sleep in each subject. The heart rate in nine consecutive 20 second epochs during REM and non-REM sleep was also obtained to derive the coefficient of variation for heart rate. and TLC 3-34 (2 02-6 33) 1. MIP was reduced to between -25 and -65 (mean -36) cm H20 (normal 107 (11-7) cm H20) and MEP to 15-50 (mean 25) cm H2O (normal 139 (10 6) cm H20). Arterial blood gas tensions with the patient breathing air were normal, Pao2 ranging from 12-5 to 15-6 (mean 14 4) kPa, and Paco2 from 4-7 to 6-1 (mean 5-3) kPa.
Oxygen was administered on the first study night to three subjects, and on the second study night to four. All subjects completed the study, with a minimum total sleep time of 352 minutes with both air and oxygen. The study time, total sleep time, and proportions of REM and non-REM sleep are given in table 1. The mean sleep onset latency was 25 7 minutes with air and 33-6 minutes with oxygen; mean REM sleep onset latency (excluding periods of awakening) was 111 5 minutes with air and 106-5 minutes with oxygen.
OXYGEN DESATURATION
Arterial oxygen saturation changes are shown in table 2. Mean Sao2 was greater with the subjects breathing oxygen rather than air, by 1-5% when they were awake (p < 0 05) and by 2 2% during non-REM sleep (p < 0 01). While breathing air, six of the seven subjects developed from 6 to 102 oxygen "desaturations" (>5%) per night; five subjects had from 2 to 68 desaturations that exceeded 10%. Desaturation of more than 5% was limited to periods of REM sleep (figure) in all but the most severely affected patient, who also showed desaturation during non-REM sleep; this subject was alone in showing any desaturation exceeding 2 5% while breathing oxygen.
BREATHING PATTERN
The dominant feature of the sleep disordered breathing in these patients was diminished chest wall movement, especially during REM sleep; this was HEART RATE Mean heart rate was 76 beats/min with air and 69 4 beats/min with oxygen. During non-REM sleep the difference in heart rate between the air and the oxygen night ranged from + 3-5% to -18 1%. The coefficient ofvariation (%) ofheart rate was greater during REM than non-REM sleep, both for air (REM 9 3 (1-6), non-REM 2-6 (0-4) (p < 0-01)) and for oxygen breathing (REM 7 2 (1.3); non-REM 2 5 (0.6) (p < 0-01)), but did not differ between air and oxygen.
AROUSALS
The frequency of arousals and awakenings combined was similar on the air and oxygen nights, being 10-4 (2.3)/h and 10 3 (1.8)/h respectively. Arousal frequency was high during REM sleep (22-2 (4-9)/h). There were significant (p < 0-01) differences in arousal and combined arousal and awakening frequency between REM and non-REM sleep with both air and oxygen. Most of the arousals and awakenings from REM sleep were associated with a documented episode of hypopnoea or apnoea of more than 10 seconds' duration-00% when subjects were breathing air and 99% when they were breathing oxygen. By contrast, during non-REM sleep only 11-5% of arousals or awakenings with air and 22% with oxygen followed documented hypopnoea. There was no relation between the number of oxygen desaturation episodes and either the arousal frequency or the sleep quality whether subjects were breathing air or oxygen.
Discussion
Duchenne muscular dystrophy provides a useful example of a condition where severe chronic respiratory weakness is uncomplicated by any obvious central ventilatory disorder when patients are awake' or, in our subjects, by substantial scoliosis or obesity. 
